Tech Company Financing Transactions

Geneos Therapeutics Funding Round

Geneos Therapeutics, based in Plymouth Meeting, raised $17 million from Flerie Invest, Global BIO Impact Fund and Inovio Pharmaceuticals.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

660 West Germantown Pike LL 100
Plymouth Meeting, PA 19462
USA

Phone

Undisclosed

Website

www.geneostx.com

Email Address

[email protected]

Overview

At Geneos Therapeutics, we believe that personalized therapies are the future of cancer treatment. Our passion is to develop personalized therapies to unleash the most powerful force against cancer -- your body's own immune system.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Niranjan Sardesai

        

Chief Financial Officer

Federica O'Brien

        

VP - Bus. Development

Hakim Hammach

        

VP - Operations

Joann Peters

        

VP - R & D

Alfredo Perales-Puchalt

        

Browse more venture capital transactions:

Prev: 3/25/2022: Nalagenetics venture capital transaction
Next: 3/25/2022: Visionary.ai venture capital transaction

Share this article

Where The Data Comes From

We do our best to record every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary